Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.
Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.
复制标题
DOI:
10.1016/j.neurobiolaging.2020.11.016
复制
发表时间:
2021-03
影响因子:
4.2
通讯作者:
Ma T
中科院分区:
文献类型:
--
作者:
Yang W;Zhou X;Ryazanov AG;Ma T
Impaired mRNA translation (protein synthesis) is linked to Alzheimer’s disease (AD) pathophysiology. Recent studies revealed a role of increased phosphorylation of eukaryotic elongation factor 2 (eEF2) in AD-associated cognitive deficits. Phosphorylation of eEF2 (at the Thr56 site) by its only known kinase eEF2K leads to inhibition of general protein synthesis. AD is considered as a disease of “synaptic failure” characterized by impairments of synaptic plasticity including long-term potentiation (LTP) and long-term depression (LTD). Deficiency of metabotropic glutamate receptor 5-dependent LTD (mGluR-LTD) is indicated in cognitive syndromes associated with various neurological disorders including AD, but the molecular signaling mechanisms underlying the mGluR-LTD dysregulation in AD remain unclear. In this brief communication, we report genetic repression of eEF2K in aged APP/PS1 AD model mice prevented AD-associated hippocampal mGluR-LTD deficits. Using pharmacological approach, we further observed that impairments of mGluR-LTD in APP/PS1 mice were rescued by treating hippocampal slices with a small molecule eEF2K antagonist NH125. Taken together, our findings suggest a critical role of abnormal protein synthesis dysregulation at the elongation phase in AD-associated mGluR-LTD failure, thus providing insights into mechanistic understanding of synaptic impairments in AD and other related dementia syndromes.
登录
查看更多内容
影响因子:
--
作者:
Kenney, Justin W.;Moore, Claire E.;Proud, Christopher G.
通讯作者:
Proud, Christopher G.
影响因子:
56.9
作者:
Huber, KM;Kayser, MS;Bear, MF
通讯作者:
Bear, MF
影响因子:
25
作者:
Ma, Tao;Trinh, Mimi A.;Wexler, Alyse J.;Bourbon, Clarisse;Gatti, Evelina;Pierre, Philippe;Cavener, Douglas R.;Klann, Eric
通讯作者:
Klann, Eric
DOI:
10.1186/alzrt260
发表时间:
2014
期刊:
Alzheimer's research & therapy
影响因子:
--
作者:
Ma T;Klann E
通讯作者:
Klann E
影响因子:
5.5
作者:
KATZ, B;MILEDI, R
通讯作者:
MILEDI, R